Grade 2 or greater peripheral neuropathy
Grade 2 or greater peripheral neuropathy
Peripheral neuropathy of severity greater than grade 1
Peripheral neuropathy greater than or equal to Grade 2
Patients with greater than or equal to grade 2 peripheral neuropathy or active herpes infection
Patients with grade 2 or greater neuropathy
Grade 2 or greater neuropathy
Current Grade greater than (>) 1 peripheral neuropathy by clinical examination
Peripheral neuropathy grade 2 or greater
Participants with baseline peripheral neuropathy greater than grade 2
Patients with greater than or equal to grade 2 peripheral neuropathy at baseline
Grade 2 or greater neuropathy
Have grade 2 or greater neuropathy at the time of screening
Uncontrolled neuropathy grade 2 or greater, regardless of cause
No prior evidence of grade 3 or greater ototoxicity or neuropathy
Patients with peripheral neuropathy greater than grade II
Has history of Grade 2 or greater peripheral neuropathy during the 3 months prior to enrollment.
Patient has peripheral neuropathy of Grade 3 or greater intensity, or painful Grade 2, as defined by the NCI CTC.
Patients with grade 2 or greater peripheral neuropathy.
Grade II or greater neuropathy at baseline
Subjects with grade 2 or greater neuropathy
Peripheral neuropathy of severity greater than grade 1
Greater than grade 1 peripheral neuropathy at baseline
Grade 2 or greater neuropathy
Peripheral neuropathy grade 2 or greater
Grade 2 or greater neuropathy [Applies to Phase 1]. Grade 3 or greater neuropathy [Applies to Phase 2].
Equal to or greater than grade 2 ataxia, cranial or peripheral neuropathy
Grade 2 or greater neuropathy
Patients must not have grade 2 or greater peripheral neuropathy
Uncontrolled neuropathy grade 2 or greater regardless of cause.
Peripheral neuropathy- grade 2 or greater
Peripheral neuropathy grade 2 or greater
Patients with grade 2 peripheral neuropathy or greater are excluded
Equal to or greater than grade 2 ataxia, cranial or peripheral neuropathy
Patients with grade II or greater peripheral neuropathy will be excluded from study
Patients with greater than or equal to grade 2 peripheral neuropathy at baseline
Peripheral neuropathy greater than Grade 1
No peripheral neuropathy greater than grade 1, due to any cause
Greater than or equal to Grade-2 neuropathy
Peripheral neuropathy of grade 2 or greater
have persistent Grade 2 or greater toxicities from any cause (except alopecia or peripheral neuropathy).
Severe neuropathy greater than or equal to grade 2
Peripheral neuropathy greater than grade 1
Grade 3 or greater edema (eg, peripheral, pulmonary)
Patients with greater than 2 screening peripheral neuropathy
Current peripheral neuropathy of NCI-CTC, version 4.0 Grade 3 or greater
Grade 2 or greater peripheral neuropathy
Peripheral neuropathy that is greater or equal to Grade 2
Has peripheral neuropathy that is greater or equal to Grade 2
The participant has any Grade 2 (or greater) peripheral neuropathy.
No grade 2 or greater peripheral neuropathy.
Peripheral neuropathy greater than or equal to grade 2.
Peripheral neuropathy greater than grade 1
Peripheral neuropathy greater than grade 1
